Farzin Haque
Stock Analyst at Jefferies
(2.76)
# 1,752
Out of 5,146 analysts
4
Total ratings
50%
Success rate
64.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Farzin Haque
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics | Initiates: Buy | $9 | $4.55 | +97.80% | 1 | Dec 22, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $5.56 | +79.86% | 1 | Sep 30, 2025 | |
| PYXS Pyxis Oncology | Assumes: Buy | $10 | $1.52 | +557.89% | 1 | May 7, 2024 | |
| VERA Vera Therapeutics | Upgrades: Buy | $18 → $26 | $41.68 | -37.62% | 1 | Nov 10, 2023 |
Relmada Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $9
Current: $4.55
Upside: +97.80%
Nuvation Bio
Sep 30, 2025
Initiates: Buy
Price Target: $10
Current: $5.56
Upside: +79.86%
Pyxis Oncology
May 7, 2024
Assumes: Buy
Price Target: $10
Current: $1.52
Upside: +557.89%
Vera Therapeutics
Nov 10, 2023
Upgrades: Buy
Price Target: $18 → $26
Current: $41.68
Upside: -37.62%